Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The future of personalised radiotherapy for head and neck cancer.

The Lancet. Oncology - 1 May 2017

Caudell Jimmy J, Torres-Roca Javier F, Gillies Robert J, Enderling Heiko, Kim Sungjune, Rishi Anupam, Moros Eduardo G, Harrison Louis B

Abstract excerpt

Radiotherapy has long been the mainstay of treatment for patients with head and neck cancer and has traditionally involved a stage-dependent strategy whereby all patients with the same TNM stage receive the same therapy. We believe there is a substantial opportunity to improve radiotherapy delive...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Combined Modality Therapy
Share to Head and Neck Neoplasms
Share to Immunotherapy

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Models, Theoretical

Share to Precision Medicine

Share to Radiation Tolerance

Share to Radiotherapy

Share to Radiotherapy Dosage

Source

Open in PubMed Open full text

Identifiers

PMID: 28456586
DOI: 10.1016/S1470-2045(17)30252-8
PMCID: PMC7771279

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026. Prepared record publication-28456586-2026-09-05.1. Manifest publication-graph-cohort-2026-09-05.1.

Source receipt: PubMed via Helena Literature Corpus, retrieved 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The future of personalised radiotherapy for head and neck cancer.PMID 28456586Read ↗

Tailoring cancer radiotherapy through genotyping, how close are we?Semantic proximity Read ↗

GARD is a pan-cancer predictor of radiation therapy benefitSemantic proximity Read ↗

Radiation therapy with phenotypic medicine: towards N-of-1 personalization.Semantic proximity Read ↗

From molecular changes to customised therapy.Semantic proximity Read ↗

Personalization of Radiotherapy Dose in HPV Positive Oropharynx Cancer Using GARDSemantic proximity Read ↗

Genomic-Adjusted Radiation Dose from Bulk RNA Sequencing for Personalized RadiotherapySemantic proximity Read ↗

Normal tissue reactions to radiotherapy: towards tailoring treatment dose by genotype.Semantic proximity Read ↗

Optimizing Clinical Outcome and Toxicity in Lung Cancer Using a Genomic Marker of RadiosensitivitySemantic proximity Read ↗

Molecular PET imaging for biology-guided adaptive radiotherapy of head and neck cancerSemantic proximity Read ↗

The genomics revolution and radiotherapy.Semantic proximity Read ↗

Towards multidimensional radiotherapy: key challenges for treatment individualisation.Semantic proximity Read ↗

[Radioresistance parameters in head and neck cancers and methods to radiosensitize].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.